Shark Tank India Season 2, Episode 34 featured CureSee Vision Therapy, a firm that debuted the first Artificial Intelligence (AI)-based Vision Therapy Software for treating disorders including Amblyopia (Lazy Eye), Squint Eye, and Convergence Insufficiency. Using artificial intelligence, the program offers patients with Amblyopia customized and adaptable treatment. Founded in 2019, the company has free eye exam available on their website. Usually, consumers find good outcomes in one to two months.
Claiming to have treated over 2,500 patients at the time of their pitch, CureSee has gotten accolades and government of India assistance. With two more studies under way, they also have one published research report bolstering their assertions of vision correction. For 3-6 month memberships, CureSee charges between 12,000 and 18,000 rupees and distributes its software through hospitals. They had 310 registered patients and brought in ₹2.64 lakh last month.
Founder: Puneet, Jatin Kaushik and Amit Sahni
Product: AI-based vision therapy website
Highlights
1. Artificial intelligence driven therapy customizes treatment for eyesight problems.
2. Alternative to Patching: Offers a digital fix meant to replace eye patches.
3. Real-time monitoring lets patients and optometre readily track changes.
4. Comparatively to conventional therapies, non-invasive and reasonably priced solutions provide an easily available answer.
5. Uses gamified therapy to make the process more interesting for patients—especially young children—so improving their engagement.
6. Clinically tested outcomes for over 2,800 patients treated show proof.
Pitch Details
Ask: ₹40 lakhs for 5% equity, valuing the company at ₹8 crores.
Deal: After negotiation Peyush Bansal, finished the deal at ₹ 50 Lakhs for 10% equity.
Investors: The investment came from Peyush Bansal.
Conclusion: With a well-researched and creative approach to vision rehabilitation, CureSee’s pitch highlighted the flaws in conventional treatments including eye patching. For those with vision problems, the scalable, efficient, and interesting AI-powered technology presents a solution. Emphasizing the clinical efficacy and market need of the platform, the founders shown great industry knowledge. Although Shark Peyush Bansal made an offer, the transaction did not occur following the broadcast. Aiming to incorporate chatbot-based order management for a better client experience, CureSee is still growing nevertheless. The startup attracted a lot of attention despite the acquisition not closing, therefore supporting its reputation and future growth capacity.
